Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Study Design in Statistics01:15

Study Design in Statistics

8.4K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.4K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

367
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
367
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

176
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
176

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relation between Time from Onset to Randomization and Benefit Magnitude in Recent Clinical Trials of Thrombectomy for Patients with Large Ischemic Cores.

Annals of Indian Academy of Neurology·2026
Same author

Optimizing rare neurological disease trials: Bayesian frameworks and hierarchical models for improved efficiency in clinical trial design.

Journal of biopharmaceutical statistics·2026
Same author

Prediction and monitoring of accrual and rate of underrepresented biomedical research group using bayesian methods.

BMC medical research methodology·2026
Same author

Unblinded by the Night: Predictive Power for Complex Bayesian Adaptive Trials When Sight Privileges Vary.

Pharmaceutical statistics·2026
Same author

Estimating Baseline Cutoffs for DHA Dosage in Preterm Birth Prevention: A Bayesian Personalized Change-Point Analysis.

Journal of applied statistics·2026
Same author

Exploring Bayesian adaptive designs in multi-arm randomized controlled trials with a patient preference arm.

Journal of biopharmaceutical statistics·2025

Related Experiment Video

Updated: Aug 29, 2025

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K

Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients.

Guangyi Gao1, Byron J Gajewski2, Jo Wick2

  • 1Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, 66160, USA. ggao1991@gmail.com.

Trials
|September 6, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a Bayesian platform trial design for binary outcomes, balancing statistical power and patient benefit. The innovative approach enhances efficiency and robustness in complex clinical trials for heterogeneous populations.

Keywords:
Bayesian modelsBeta-binomialHierarchical modelsPlatform trial designResponse-adaptive randomization

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K
Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

5.9K

Related Experiment Videos

Last Updated: Aug 29, 2025

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K
Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

5.9K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Bayesian Inference

Background:

  • Platform trials offer flexibility for multiple treatments and patient subgroups.
  • Optimized, transparent, and rigorous designs are crucial for complex platform trials.
  • Key considerations include cost-efficiency, statistical power, patient benefit, and robustness.

Purpose of the Study:

  • To present a novel Bayesian platform trial design for binary outcomes.
  • To address the need for optimized, transparent, and rigorous trial designs.
  • To improve efficiency, statistical power, and patient benefit in platform trials.

Main Methods:

  • A Bayesian platform trial design using a beta-binomial model for binary outcomes.
  • Incorporates hierarchical modeling for subgroup analysis and information borrowing.
  • Utilizes response-adaptive randomization (RAR) and adjusts for temporal drift.

Main Results:

  • The proposed design achieved high statistical power and good patient benefit.
  • Demonstrated robustness against population drift over time.
  • Offered a balanced approach between RAR and fixed 1:1 allocation.

Conclusions:

  • The Bayesian platform trial design is a promising choice for dichotomous outcome trials.
  • Effectively balances statistical power, patient benefit, and adaptability.
  • Suitable for trials investigating multiple patient subgroups, such as in ischemic stroke.